Influenza virosomes as vaccine adjuvant and carrier system

Vaccination for the prevention and treatment of breast cancer with special focus on Her-2/neu peptide vaccines

(2013) Ursula Wiedermann et al.   BREAST CANCER RESEARCH AND TREATMENT

The application of virus-like particles to human diseases

(2013) Franco Buonaguro et al.   Expert Review of Vaccines

Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes

(2013) Geert Leroux-Roels et al.   PLoS One

Cationic influenza virosomes as an adjuvanted delivery system for CTL induction by DNA vaccination

(2012) Abbas Jamali et al.   IMMUNOLOGY LETTERS

Immunogenicity and Protective Capacity of a Virosomal Respiratory Syncytial Virus Vaccine Adjuvanted with Monophosphoryl Lipid A in Mice

(2012) Tobias Kamphuis et al.   PLoS One

A virosomal vaccine against candidal vaginitis: Immunogenicity, efficacy and safety profile in animal models

(2012) Flavia De Bernardis et al.   VACCINE

Virosome: A novel vector to enable multi-modal strategies for cancer therapy

(2011) Yasufumi Kaneda   ADVANCED DRUG DELIVERY REVIEWS

Successful Memory Response following a Booster Dose with a Virosome-Formulated Hepatitis A Vaccine Delayed Up to 11 Years

(2011) Christoph Hatz et al.   Clinical and Vaccine Immunology

Influenza virosomes as a vaccine adjuvant and carrier system

(2011) Christian Moser et al.   Expert Review of Vaccines

Developments in virus-like particle-based vaccines for infectious diseases and cancer

(2011) Luigi Buonaguro et al.   Expert Review of Vaccines

A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) ofCandida albicansas a mucosal anticandidal vaccine

(2011) Silvia Sandini et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges

(2011) Morgane Bomsel et al.   IMMUNITY

Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations

(2011) Marco Tamborrini et al.   MALARIA JOURNAL

Virosome-Formulated Plasmodium falciparum AMA-1 & CSP Derived Peptides as Malaria Vaccine: Randomized Phase 1b Trial in Semi-Immune Adults & Children

(2011) Patrick Georges Cech et al.   PLoS One

Evaluation of the Sublingual Route for Administration of Influenza H5N1 Virosomes in Combination with the Bacterial Second Messenger c-di-GMP

(2011) Gabriel Kristian Pedersen et al.   PLoS One

Immunogenicity and tolerability of a paediatric presentation of a virosomal hepatitis A vaccine in Chilean children aged 1–16 years

(2011) Katia Abarca et al.   VACCINE

Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial

(2011) Rebecca J. Cox et al.   VACCINE

Intranasal Immunization with Influenza VLPs Incorporating Membrane-Anchored Flagellin Induces Strong Heterosubtypic Protection

(2010) Bao-Zhong Wang et al.   PLoS One

Enhancement of immunogenicity of a virosome-based avian influenza vaccine in chickens by incorporating CpG-ODN

(2010) Amirul Islam Mallick et al.   VACCINE

A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study

(2009) Ursula Wiedermann et al.   BREAST CANCER RESEARCH AND TREATMENT

Virosomal Hepatitis A Vaccine: Comparing Intradermal and Subcutaneous With Intramuscular Administration

(2009) Gert Frösner et al.   JOURNAL OF TRAVEL MEDICINE

HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection: an IgA gene and functional analysis

(2009) D Tudor et al.   Mucosal Immunology

Pseudovirions as Vehicles for the Delivery of siRNA

(2009) Paul E. Lund et al.   PHARMACEUTICAL RESEARCH

Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin

(2009) David J. M. Lewis et al.   PLoS One

Eleven years of Inflexal® V—a virosomal adjuvanted influenza vaccine

(2009) Christian Herzog et al.   VACCINE

The coming of age of virus-like particle vaccines

(2008) Gary T. Jennings et al.   BIOLOGICAL CHEMISTRY

Contribution of influenza immunity and virosomal-formulated synthetic peptide to cellular immune responses in a phase I subunit malaria vaccine trial

(2008) Elisabetta Peduzzi et al.   CLINICAL IMMUNOLOGY

Nanoparticles target distinct dendritic cell populations according to their size

(2008) Vania Manolova et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Recent advances with a virosomal hepatitis A vaccine

(2008) Patrick A Bovier   EXPERT OPINION ON BIOLOGICAL THERAPY

Epaxal®: a virosomal vaccine to prevent hepatitis A infection

(2008) Patrick A Bovier   Expert Review of Vaccines

Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial

(2008) Fiona M. Thompson et al.   PLoS One

Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: Impact of distinct additional adjuvants

(2008) Katarina Radošević et al.   VACCINE

Safe vaccination of children with a virosomal adjuvanted influenza vaccine

(2008) Valérie Künzi et al.   VACCINE